Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.0197 per EA under NDC 60687086101. Its NADAC has been published 71 times since Apr 16, 2025.
FDA first approved this application on Jun 28, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
American Health PackagingNDC
60687086101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856FDA Approved
6/28/2006
TE Code
AB
On Market Since
3/20/2025
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 71 times since Apr 16, 2025, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0197 per EA |
|---|---|
| All-time high | $0.0224 (Sep 10, 2025) |
| All-time low | $0.0197 (Jul 22, 2026) |
| 52-week high | $0.0224 |
| 52-week low | $0.0197 |
| Median price | $0.0216 |
| Average price | $0.0212 |
| Largest weekly change | -3.5% (Feb 18, 2026) |
| Weeks tracked | 71 |
| Tracking since | Apr 16, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by American Health Packaging, is $0.0197 per EA (NDC 60687086101), effective Aug 19, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has declined 9.4%. It has been tracked across 71 weekly CMS publications since Apr 16, 2025.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since Apr 16, 2025, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0197 (Jul 22, 2026) to a high of $0.0224 (Sep 10, 2025), with a median of $0.0216 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 60687086101) is labeled by American Health Packaging, and CMS classifies it as a generic product.